Entrada Therapeutics Inc (TRDA)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | ||||||
Total Revenue | 0 | 0 | 0 | 25.26M | 18.17M | 43.74M | 41.85M | 59.12M |
Operating Income | -23.58M | -25.94M | -25.58M | -5.78M | -16.3M | 14.01M | 4.91M | 21.11M |
Pre Tax Income | -23.18M | -25.14M | -24.63M | -3.12M | -12.08M | 18.06M | 9.2M | 25.33M |
Net Income | -23.18M | -25.14M | -24.63M | -6.67M | -25.93M | 35.46M | -9.54M | 23.5M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -23.58M | -25.94M | -25.58M | -5.78M | -16.3M | 14.01M | 4.91M | 21.11M |
EBITDA | -23.12M | -25.42M | -25.05M | -5.24M | -15.57M | 14.85M | 5.64M | 22.05M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 129.01M |
Operating Income | -51.13M | -97.25M | -3.16M |
Pre Tax Income | -51.16M | -94.62M | 12.06M |
Net Income | -51.16M | -94.62M | -6.69M |
Preferred Dividends | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.638 | -3.014 | -0.2 |
EBIT | -51.13M | -97.25M | -3.16M |
EBITDA | -50.03M | -95.35M | -321k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.